药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arformoterol
Delamanid
Rilpivirine may increase the QTc-prolonging activities of Delamanid.
Arformoterol
Tenofovir
The excretion of Tenofovir can be decreased when combined with Rilpivirine.
Arformoterol
Fosamprenavir
The serum concentration of Rilpivirine can be increased when it is combined with Fosamprenavir.
Arformoterol
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Rilpivirine.
Arformoterol
Lumefantrine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Lumefantrine.
Arformoterol
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Zuclopenthixol.
Arformoterol
Ribociclib
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Ribociclib.
Arformoterol
Terodiline
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Terodiline.
Arformoterol
Macimorelin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Macimorelin.
Arformoterol
Ivabradine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Ivabradine.
Arformoterol
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Tetrabenazine.
Arformoterol
Temafloxacin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Temafloxacin.
Arformoterol
Lithium cation
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Lithium cation.
Arformoterol
Gilteritinib
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Gilteritinib.
Arformoterol
Benidipine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Benidipine.
Arformoterol
Nilvadipine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Nilvadipine.
Arformoterol
Dexverapamil
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Dexverapamil.
Arformoterol
Penfluridol
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Penfluridol.
Arformoterol
Otilonium
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Otilonium.
Arformoterol
Eperisone
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Eperisone.